Management of dyslipidemia in renal disease and transplantation.
Zolezzi
Monica
M
D002318:Cardiovascular Diseases / Q000209:etiology; D002784:Cholesterol / Q000097:blood; D050171:Dyslipidemias / Q000188:drug therapy* / Q000503:physiopathology; D005229:Fatty Acids, Monounsaturated / Q000627:therapeutic use; D000077340:Fluvastatin; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007211:Indoles / Q000627:therapeutic use; D007674:Kidney Diseases / Q000150:complications*; D016030:Kidney Transplantation; D050356:Lipid Metabolism / Q000187:drug effects; D017410:Practice Guidelines as Topic; D006435:Renal Dialysis; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood
D005229:Fatty Acids, Monounsaturated; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007166:Immunosuppressive Agents; D007211:Indoles; D014280:Triglycerides; D000077340:Fluvastatin; D002784:Cholesterol